The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Fungal Biofilms
Open accessAbstract
Biofilms are a principal form of microbial growth and are critical to development of clinical infection. They are responsible for a broad spectrum of microbial infections in the human host. Many medically important fungi produce biofilms, including Candida [1], Aspergillus [2], Cryptococcus [3], Trichosporon [4], Coccidioides [5], and Pneumocystis [6]. In this review we emphasize common features among fungal biofilms, and point toward genes and pathways that may have conserved roles. Biofilm cell communities are more resistant to antifungal drugs than planktonic cells. Contributing factors include biofilm structural complexity, presence of extracellular matrix (ECM), metabolic heterogeneity intrinsic to biofilms, and biofilm-associated up-regulation of efflux pump genes. The actual fold increase in resistance varies with both the drug and species. Candida albicans and Candida parapsilosis biofilms are relatively resistant to fluconazole, amphotericin B, nystatin, voriconazole, and others. Aspergillus fumigatus biofilms are relatively resistant to itraconazole and, to some extent, to caspofungin. Cryptococcal biofilms are unaffected by fluconazole and voriconazole, and biofilms of Trichosporon asahii display elevated resistance to amphotericin B, caspofungin, voriconazole, and fluconazole. Azole and amphotericin B therapies are ineffective against Pneumocystis carinii biofilms. Biofilm-associated resistance mechanisms have been characterized in C. albicans and A. fumigatus and include drug binding by ECM and production of persister cells [2,7] (see supplementary references for this section in Text S1). Persister cells represent only a fraction of the population, and probably reflect its metabolic heterogeneity. These mechanisms may pertain to other fungi as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the single-celled morphology of yeasts also favours adhesion and biofilm formation, which directly influences environmental persistence, competitiveness and thereby improved biocontrol activity (Fanning and Mitchell 2012; Pandin et al. 2017; Rossouw et al. 2018; Verstrepen and Klis 2006).”
From Biocontrol yeasts: mechanisms and applications (2019) · cites this paper as Fanning and Mitchell 2012
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic control of Candida albicans biofilm development
Finkel, J. S., & Mitchell, A. P. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2475 · Cited by 612 · cited 6×
“ALS1 is the most upregulated of the known adherence genes of C. albicans under biofilm conditions. Garcia-Sanchez et al. (2004) [26] highlight that the ALS genes are differentially expressed in biofilms and have autonomous contributions in the biofilm transcriptome. Nett et al. (2009) [25] observed differential expres…”
BackgroundInfluentialSelf-citationAl-Fattani, M. A., & Douglas, L. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46569-0 · Cited by 548
Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells
LaFleur, M. D., Kumamoto, C. A., & Lewis, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00684-06 · Cited by 521
Andes, D., Nett, J., Oschel, P., Albrecht, R., Marchillo, K., & Pitula, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.6023-6031.2004 · Cited by 389
García-Sánchez, S., Aubert, S., Iraqui, I., Janbon, G., Ghigo, J.-M., & d'Enfert, C. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.2.536-545.2004 · Cited by 353
Adherence and biofilm formation of non-Candida albicans Candida species
Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.02.003 · Cited by 304
Candida albicans forms biofilms on the vaginal mucosa
Harriott, M. M., Lilly, E. A., Rodriguez, T. E., Fidel, P. L., & Noverr, M. C. (2010) · Microbiology · doi:10.1099/mic.0.039354-0 · Cited by 301
In vivo biofilm composition of Aspergillus fumigatus
Loussert, C., Schmitt, C., Prevost, M.-C., Balloy, V., Fadel, E., Philippe, B., Kauffmann-Lacroix, C., Latgé, J. P., & Beauvais, A. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01409.x · Cited by 269
Martins, M., Uppuluri, P., Thomas, D. P., Cleary, I. A., Henriques, M., Lopez-Ribot, J. L., & Oliveira, R. (2010) · Mycopathologia · doi:10.1007/s11046-009-9264-y · Cited by 250
Di Bonaventura, G., Pompilio, A., Picciani, C., Iezzi, M., D'Antonio, D., & Piccolomini, R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00556-06 · Cited by 226
Cited by
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848
Essential Oils and Antifungal Activity
Nazzaro, F., Fratianni, F., Coppola, R., & Feo, V. D. (2017) · Pharmaceuticals · doi:10.3390/ph10040086 · Cited by 817
“Inhibition of biofilm development Coriandrum sativum [59] Croton cajucara [60,61] Cymbopogon [62–65] Cytrus [66] Eucalyptus [62] Laurus nobilis [67] Litsea [35] Melaleuca alternifolia [38,68,69] Mentha [62,70] Myrtus communis [71] Ocimum [72,73] Piper claussenianum [74] Rosmarinus officinalis [75] Inhibition of biofil…”
BackgroundInfluentialTariq, S., Wani, S., Rasool, W., Shafi, K., Bhat, M. A., Prabhakar, A., Shalla, A. H., & Rather, M. A. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103580 · Cited by 693
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Campoy, S., & Adrio, J. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.019 · Cited by 511
Metadata
- Authors
- Fanning, S., & Mitchell, A. P.
- Affiliations
- Duke Medical Center (US)
- Carnegie Mellon University (US)
- Corresponding author
- Mitchell, Aaron P.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-04-05
- Volume
- 8
- Issue
- 4
- Pages
- e1002585
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3320593
- OpenAlex
- W3187158005
- Cited by
- 465
- References
- 30
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 30 · 2023: 46 · 2022: 32 · 2021: 41 · 2020: 43 · 2019: 41 · 2018: 24 · 2017: 36 · 2016: 33 · 2015: 29 · 2014: 24 · 2013: 15 · 2012: 6
- FWCI
- 16.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Andrew W. Mellon Foundation
- Richard King Mellon Foundation
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI067703)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- fungal biofilms, biofilm formation, fungal pathogens
- MeSH terms
- Antifungal Agents, Fungi, Species Specificity, Biofilms, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fungal Biofilms. https://app.cochat.ai/papers/10.1371/journal.ppat.1002585
- The paper
- Fanning, S., & Mitchell, A. P. (2012). Fungal Biofilms. PLoS Pathogens. https://doi.org/10.1371/journal.ppat.1002585
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.